Dexcom (DXCM) Total Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Total Non-Current Liabilities data on file, last reported at $3.5 billion in Q1 2026.

• Quarterly Total Non-Current Liabilities fell 18.46% year-over-year to $3.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 billion (down 18.46% YoY) and the FY2025 annual result came in at $3.5 billion, down 18.36% from the prior year.
• Total Non-Current Liabilities advanced to $3.5 billion in Q1 2026 per DXCM's latest filing, from $3.5 billion in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $4.6 billion in Q3 2025 and bottomed at $2.8 billion in Q1 2022.
• The 5-year median for Total Non-Current Liabilities is $4.1 billion (2024), against an average of $3.8 billion.
• The widest annual swing landed in 2023, when Total Non-Current Liabilities soared 60.28%; it then dropped 18.46% in 2026.
• Tracing DXCM's Total Non-Current Liabilities over 5 years: stood at $3.1 billion in 2022, then grew by 29.98% to $4.1 billion in 2023, then advanced by 4.02% to $4.2 billion in 2024, then decreased by 18.36% to $3.5 billion in 2025, then gained by 2.25% to $3.5 billion in 2026.
• Per Business Quant, the three latest DXCM Total Non-Current Liabilities figures stand at $3.5 billion (Q1 2026), $3.5 billion (Q4 2025), and $4.6 billion (Q3 2025).

Peer Comparison